Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Baxter International ( (BAX) ) has issued an announcement.
On February 3, 2025, Baxter International announced the transition of José E. Almeida from his roles as CEO and Chair to a non-executive advisory position, effective the same day, with Brent Shafer appointed as interim CEO and Chair. The company has initiated a search for a permanent CEO while appointing Heather Knight as Chief Operating Officer. These leadership changes are aligned with Baxter’s strategic transformation and growth objectives, following significant business repositioning under Almeida’s tenure.
More about Baxter International
Baxter International Inc. is a global leader in medtech, providing a comprehensive range of diagnostic, critical care, nutrition, hospital, and surgical products. The company operates across various healthcare settings, including patient homes, hospitals, and physician offices, with products and solutions available in over 100 countries.
YTD Price Performance: 11.28%
Average Trading Volume: 4,730,978
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $16.62B
See more insights into BAX stock on TipRanks’ Stock Analysis page.
